More than 4,000 voices and over 10 provider groups united through the Speech Therapy Action Taskforce to advocate for children’s access to care
[White Plains, NY, November 10, 2026] — Ivy Health today announced an important milestone in the effort to protect children’s access to pediatric speech therapy. The Centers for Medicare & Medicaid Services (CMS) has finalized a new pediatric speech therapy code, G0903, as part of its 2027 Medicare Physician Fee Schedule, following a coordinated advocacy effort by the Speech Therapy Action Taskforce (STAT).
The decision follows a proposed 13% reduction in pediatric speech therapy reimbursement that raised concerns about children’s access to care. In response, Ivy Health helped lead STAT, bringing together more than 4,000 voices and over 10 provider groups around one shared goal: keep speech therapy within reach of every child.
Clinicians, families, and advocates shared their perspectives with CMS, highlighting the importance of speech therapy for children learning to communicate, building new skills, and connecting with the world around them.
“When we saw what was at stake for children’s access to speech therapy, we knew we couldn’t sit on the sidelines,” said Jason Strauss, CEO of Ivy Health. “As a parent of children who have needed speech therapy, I have seen the amazing impact speech therapy provides and how challenging it can be to find care. Thousands of people came together because this care matters, and we are very grateful to CMS for hearing our message. This is a win worth celebrating, and it belongs to every family, clinician, and organization that spoke up.”
The new Medicare-specific pediatric speech-language pathology treatment code, G0903, takes effect January 1, 2027.
“Children aren’t simply small adults, and the care they need shouldn’t be treated as though they are,” said Dan Murrey, MD, Chief Medical Officer of Ivy Health. “Pediatric speech therapy requires an approach built around each child’s developmental needs. We appreciate CMS and the AMA for listening thoughtfully and recognizing that distinction. We are grateful to everyone who helped bring attention to the importance of keeping this care accessible.”
Ivy Health thanks CMS for considering public feedback and recognizes every family, clinician, and partner who supported the effort. STAT welcomes conversations with other healthcare organizations interested in supporting future advocacy.
For more information, visit https://stat-usa.org/.
Media Contact:
Ivy Communications
[email protected]